BIOMAT Database Logo BIOMAT Database Logo

Clinical Progress Note: Procalcitonin in the Diagnosis and Management of Community-Acquired Pneumonia in Hospitalized Adults. 2019

Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
Division of Hospital Medicine, Department of Medicine, New York-Presbyterian-Weill Cornell Medical Center, New York, New York.

UI MeSH Term Description Entries
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077740 Procalcitonin A peptide prohormone precursor of CALCITONIN. It is normally present at low levels in serum, but is released into the bloodstream, primarily from neuroendocrine cells in the lungs and intestines, in response to INFLAMMATION and BACTERIAL INFECTIONS. It is a diagnostic marker for BACTEREMIA. Calcitonin Precursor Polyprotein,Calcitonin Related Polypeptide Alpha,Calcitonin-1,Pro-Calcitonin,Calcitonin 1
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D017714 Community-Acquired Infections Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility. Community Acquired Infection,Community-Acquired Infection,Infections, Community-Acquired,Acquired Infection, Community,Acquired Infections, Community,Community Acquired Infections,Infection, Community Acquired,Infection, Community-Acquired,Infections, Community Acquired
D019468 Disease Management A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596) Disease Managements,Management, Disease,Managements, Disease

Related Publications

Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
Clinical progress note: Update in management in community acquired pneumonia in children.
September 2023, Journal of hospital medicine,
Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia.
May 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia.
July 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
Community-Acquired Pneumonia in Adults: Diagnosis and Management.
November 2016, American family physician,
Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
Diagnosis and management of community-acquired pneumonia in adults.
June 2011, American family physician,
Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
[Clinical management of community-acquired pneumonia in adults].
June 2009, Medicina clinica,
Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
[Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults].
June 2001, Presse medicale (Paris, France : 1983),
Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia.
February 2004, European journal of internal medicine,
Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels.
January 2009, Scandinavian journal of infectious diseases,
Justin J Choi, and Matthew W McCarthy, and Matthew S Simon, and Arthur T Evans, and Wesley H Self, and Marshall J Glesby
[Clinical and radiological diagnosis of community-acquired pneumonia in adults].
January 2005, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
Copied contents to your clipboard!